| Literature DB >> 33612998 |
Plácido L Vidal1,2, Joaquim Moura1,2, Jorge Novo1,2, Marcos Ortega1,2.
Abstract
One of the main challenges in times of sanitary emergency is to quickly develop computer aided diagnosis systems with a limited number of available samples due to the novelty, complexity of the case and the urgency of its implementation. This is the case during the current pandemic of COVID-19. This pathogen primarily infects the respiratory system of the afflicted, resulting in pneumonia and in a severe case of acute respiratory distress syndrome. This results in the formation of different pathological structures in the lungs that can be detected by the use of chest X-rays. Due to the overload of the health services, portable X-ray devices are recommended during the pandemic, preventing the spread of the disease. However, these devices entail different complications (such as capture quality) that, together with the subjectivity of the clinician, make the diagnostic process more difficult and suggest the necessity for computer-aided diagnosis methodologies despite the scarcity of samples available to do so. To solve this problem, we propose a methodology that allows to adapt the knowledge from a well-known domain with a high number of samples to a new domain with a significantly reduced number and greater complexity. We took advantage of a pre-trained segmentation model from brain magnetic resonance imaging of a unrelated pathology and performed two stages of knowledge transfer to obtain a robust system able to segment lung regions from portable X-ray devices despite the scarcity of samples and lesser quality. This way, our methodology obtained a satisfactory accuracy of 0.9761 ± 0.0100 for patients with COVID-19, 0.9801 ± 0.0104 for normal patients and 0.9769 ± 0.0111 for patients with pulmonary diseases with similar characteristics as COVID-19 (such as pneumonia) but not genuine COVID-19.Entities:
Year: 2021 PMID: 33612998 PMCID: PMC7879025 DOI: 10.1016/j.eswa.2021.114677
Source DB: PubMed Journal: Expert Syst Appl ISSN: 0957-4174 Impact factor: 6.954
Summary of some representative works of the state of the art in comparison with our proposal. As shown, none of them work in lung chest segmentation of images from portable devices and are able to work with a significantly limited dataset.
| Author | Objective | Strategy | Image types |
|---|---|---|---|
| COVID-19 detection | Thresholding Support Vector Machine | General purpose chest radiographs | |
| COVID-19 detection | Combination of two CNN and an SVM to generate a joint model | Computerized Tomography Images | |
| COVID-19 detection | Resnet50 to extract deep features and SVM for classification | General purpose chest radiographs | |
| COVID-19 classification (Normal, COVID-19, Pneumonia) | Transfer learning from generic domains | General purpose chest radiographs | |
| COVID-19 classification (Normal, COVID-19, Pneumonia) | CNN + Long Short-Term Memory networks | General purpose chest radiographs | |
| COVID-19 classification (Normal, COVID-19, Pneumonia) | Concatenation of two CNNs | General purpose chest radiographs | |
| COVID-19 classification (COVID-19, normal, bacterial pneumonia, and viral pneumonia) with a limited dataset | Generative Adversarial Networks and Transfer Learning | General purpose chest radiographs | |
| COVID-19 classification (Normal, COVID-19, Pneumonia) | Bayesian-optimized CNN | General purpose chest radiographs | |
| COVID-19 classification (No, COVID-19, Pneumonia) | You Only Look Once object detection with DarkNet CNN | General purpose chest radiographs | |
| COVID-19 classification (Normal, COVID-19, Pneumonia) | U-Net CNN | General purpose chest radiographs | |
| COVID-19 classification (Normal, COVID-19, Pneumonia) | U-Net CNN | Chest radiographs exclusively from portable devices | |
| Segmentation of lung and COVID-19 regions in CT images | U-Net CNN | Computerized Tomography Images | |
| COVID-19 lung infection segmentation | Inf-Net CNN | Computerized Tomography Images | |
| Lung and COVID-19 infected regions segmentation in CT | Residual Attention U-Net | Computerized Tomography Images | |
| COVID-19 detection | Anomaly detection with a Confidence-aware anomaly detection CNN | General purpose chest radiographs | |
| COVID-19 detection, lung segmentation and infected region localization | Inception Recurrent Residual Neural Network for detection and NABLA-N network for segmentation | General purpose chest radiographs | |
| Ours | Lung region segmentation (Normal, COVID-19, Pneumonia) with a limited dataset and poor image quality | Two-stage transfer learning from MRI glioma segmentation to general purpose chest radiographs to portable device chest radiographs with U-Net CNN | Chest radiographs exclusively from portable devices |
Fig. 1Examples of images from portable devices for patients diagnosed with COVID-19, non-COVID-19 pathological lungs with similar characteristics and with normal lungs.
Fig. 2Example of the main features present in COVID-19 lung radiographs. (a) Image with ground glass abnormalities. (b) Image with dense/lattice consolidations.
Fig. 3Architecture of the pretrained convolutional neural network. Notice the encoder-decoder strategy with skip-connections, ideal for medical imaging segmentaton.
Specifications of the equipment used throughout the project to carry out the experiments.
| Name | Description |
|---|---|
| OS | Ubuntu 18.04.5 LTS (Bionic Beaver) |
| Kernel | Linux 4.15.0–128-generic |
| Architecture | x86-64 |
| CPU | Intel(R) Core(TM) i9-9900 K CPU @ 3.60 GHz |
| Motherboard | ASUS PRIME Z390-A |
| RAM | 2 x 16GiB DIMM DDR4 Synchronous 2666 MHz CRUCIAL BLT16G4D26BFT4.C16FD |
| HDD | ATA Disk TOSHIBA DT01ACA2 1863GiB (2 TB) |
| GPU | NVIDIA Corporation GeForce RTX 2080 Ti |
| Driver Version | 450.51.06 |
| CUDA Version | 11.0 |
Fig. 4Diagram of the fully automatic methodology to obtain a model able to segment lung regions in radiographs from portable devices.
Fig. 5Example MRI images and chest radiographs with gradient, texture and intensity patterns similar between domains.
Fig. 6Algorithm followed during each repetition, including the data augmentation process and early stopping configuration (the latter based on the validation error).
Fig. 7Training and validation loss for the 25 repetitions for the inter domain knowledge transfer stage.
Mean and standard deviation of test results for the 25 repetitions of the inter domain knowledge transfer stage.
| ACC | AUC | DICE | JACC | PREC | RECA | F1-SC | SENS | SPEC | |
|---|---|---|---|---|---|---|---|---|---|
| Mean | 0.8813 | 0.9702 | 0.9554 | 0.9156 | 0.9064 | 0.8267 | 0.8366 | 0.6703 | 0.9832 |
| St. dev. | 0.0855 | 0.0244 | 0.0250 | 0.0432 | 0.0573 | 0.1247 | 0.1315 | 0.2528 | 0.0132 |
Fig. 8Training and validation loss for the 25 repetitions for the inter device type knowledge transfer stage.
Mean and standard deviation of test results for the 25 repetitions of the inter device type knowledge transfer stage.
| ACC | AUC | DICE | JACC | PREC | RECA | F1-SC | SENS | SPEC | |
|---|---|---|---|---|---|---|---|---|---|
| Mean | 0.9773 | 0.9695 | 0.9436 | 0.8936 | 0.9656 | 0.9644 | 0.9641 | 0.9423 | 0.9864 |
| St. dev. | 0.0097 | 0.0243 | 0.0243 | 0.0419 | 0.0175 | 0.0228 | 0.0152 | 0.0500 | 0.0107 |
Breakdown of the results from the model from the inter domain knowledge transfer stage tested with the CHUAC dataset and by pathology.
| ACC | AUC | DICE | JACC | PREC | RECA | F1-SC | SENS | SPEC | |
|---|---|---|---|---|---|---|---|---|---|
| Mean | 0.9570 | 0.9377 | 0.8936 | 0.8142 | 0.9481 | 0.9286 | 0.9348 | 0.8729 | 0.9844 |
| St. dev. | 0.0293 | 0.0318 | 0.0698 | 0.1046 | 0.0471 | 0.0372 | 0.0418 | 0.0745 | 0.0230 |
| Mean | 0.9555 | 0.9326 | 0.8854 | 0.8014 | 0.9484 | 0.9220 | 0.9305 | 0.8576 | 0.9864 |
| St. Dev. | 0.0439 | 0.0288 | 0.0731 | 0.1073 | 0.0473 | 0.0493 | 0.0588 | 0.0973 | 0.0197 |
| Mean | 0.9476 | 0.9228 | 0.8536 | 0.7551 | 0.9268 | 0.9145 | 0.9173 | 0.8536 | 0.9754 |
| St. dev. | 0.0294 | 0.0323 | 0.0928 | 0.1293 | 0.0584 | 0.0346 | 0.0468 | 0.0608 | 0.0286 |
Breakdown of the results from the model from the inter device type transfer learning stage tested with the CHUAC dataset and by pathology.
| ACC | AUC | DICE | JACC | PREC | RECA | F1-SC | SENS | SPEC | |
|---|---|---|---|---|---|---|---|---|---|
| Mean | 0.9761 | 0.9705 | 0.9447 | 0.8961 | 0.9653 | 0.9655 | 0.9644 | 0.9444 | 0.9867 |
| St. dev. | 0.0100 | 0.0204 | 0.0241 | 0.0411 | 0.0205 | 0.0193 | 0.0145 | 0.0443 | 0.0108 |
| Mean | 0.9801 | 0.9752 | 0.9528 | 0.9103 | 0.9724 | 0.9688 | 0.9701 | 0.9470 | 0.9906 |
| St. dev. | 0.0104 | 0.0158 | 0.0161 | 0.0288 | 0.0122 | 0.0171 | 0.0115 | 0.0373 | 0.0059 |
| Mean | 0.9769 | 0.9649 | 0.9414 | 0.8910 | 0.9674 | 0.9616 | 0.9637 | 0.9340 | 0.9891 |
| St. dev. | 0.0111 | 0.0334 | 0.0322 | 0.0532 | 0.0184 | 0.0256 | 0.0189 | 0.0525 | 0.0077 |
Fig. 9Comparison between the model trained with common chest radiographs and the model adapted to portable devices for images from patients diagnosed with COVID-19.
Fig. 10Comparison between the model trained with common chest radiographs and the model adapted to portable devices for images from patients without lung afflictions.
Fig. 11Comparison between the model trained with common chest X-ray radiographs and the model adapted to portable devices for images from patients diagnosed with lung afflictions similar to COVID-19 (such as pneumonia) but not COVID-19 related.
Mean time and standard deviation in milliseconds for each knowledge transfer stage.
| Mean | Standard deviation | |||
|---|---|---|---|---|
| Transfer stage | MRI to General | General to Portable | MRI to General | General to Portable |
| Training | 35,413.26 | 1,857.17 | 42.92 | 13.17 |
| Validation | 3,910.10 | 353.18 | 17.17 | 11.74 |
Fig. 12Sample images of the network output from the inter domain transfer learning stage (red) and inter device learning stage (blue). (a): Normal, (b): COVID-19, (c) & (d): Non-covid lung pathologies. First row: original image, Second row: comparison between models.
Fig. 13Sample images with unwanted artifacts and formations from the inter domain transfer learning stage (red) and that same output from the inter device type learning stage (blue). (a): Normal, (b): COVID-19, (c): Non-covid lung pathologies. First row: original image, Second row: comparison between models.